Literature DB >> 27183588

Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production.

Yu Zhan1, Sergey S Seregin1, Jiachen Chen1, Grace Y Chen2.   

Abstract

Chronic intestinal inflammation is a major risk factor for the development of colorectal cancer. Nod1, a member of the Nod-like receptor (NLR) family of pattern recognition receptors, is a bacterial sensor that has been previously demonstrated to reduce susceptibility of mice to chemically induced colitis and subsequent tumorigenesis, but the mechanism by which it mediates its protection has not been elucidated. In this study, we show that Nod1 expression in the hematopoietic cell compartment is critical for limiting inflammation-induced intestinal tumorigenesis. Specifically, Nod1-deficient T cells exhibit impaired IFN-γ production during dextran sulfate sodium (DSS)-induced acute inflammation in vivo, and administration of the Nod1 ligand KF1B enhances IFN-γ responses by anti-CD3-activated T cells in vitro. Absence of IFN-γ signaling results in increased inflammation-associated tumors in mice, and adoptive transfer of Nod1(-/-) or IFNγ(-/-) T cells into T cell-deficient mice results in increased tumorigenesis as compared with T cell-deficient mice that were adoptively transferred with wild-type T cells. Collectively, these results suggest a previously unappreciated role for the innate immune receptor Nod1 in suppressing colitis-associated tumorigenesis through a T cell-mediated mechanism.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183588      PMCID: PMC4893968          DOI: 10.4049/jimmunol.1501822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  IFN-γ-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-α-driven microenvironment in patients with colon carcinoma.

Authors:  Sandra Grenz; Elisabeth Naschberger; Susanne Merkel; Nathalie Britzen-Laurent; Ute Schaal; Andreas Konrad; Michael Aigner; Tilman T Rau; Arndt Hartmann; Roland S Croner; Werner Hohenberger; Michael Stürzl
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

Review 2.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

3.  Interaction of NF-kappaB and NFAT with the interferon-gamma promoter.

Authors:  A Sica; L Dorman; V Viggiano; M Cippitelli; P Ghosh; N Rice; H A Young
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

4.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

5.  Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.

Authors:  Jeremy Dupaul-Chicoine; Garabet Yeretssian; Karine Doiron; Kirk S B Bergstrom; Christian R McIntire; Philippe M LeBlanc; Charles Meunier; Claire Turbide; Philippe Gros; Nicole Beauchemin; Bruce A Vallance; Maya Saleh
Journal:  Immunity       Date:  2010-03-11       Impact factor: 31.745

6.  Interferon-γ modulates intestinal epithelial cell function in-vitro through a TGFβ-dependent mechanism.

Authors:  Peter Hoffmann; Andreas Sturm; Jürgen Stein; Axel U Dignass
Journal:  Regul Pept       Date:  2011-03-05

7.  Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury.

Authors:  Yu Zhan; Po-Ju Chen; William D Sadler; Fuyuan Wang; Sara Poe; Gabriel Núñez; Kathryn A Eaton; Grace Y Chen
Journal:  Cancer Res       Date:  2013-10-28       Impact factor: 12.701

8.  NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis.

Authors:  Eran Elinav; Till Strowig; Andrew L Kau; Jorge Henao-Mejia; Christoph A Thaiss; Carmen J Booth; David R Peaper; John Bertin; Stephanie C Eisenbarth; Jeffrey I Gordon; Richard A Flavell
Journal:  Cell       Date:  2011-05-12       Impact factor: 41.582

9.  T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.

Authors:  Michael H Shaw; Thornik Reimer; Carmen Sánchez-Valdepeñas; Neil Warner; Yun-Gi Kim; Manuel Fresno; Gabriel Nuñez
Journal:  Nat Immunol       Date:  2009-11-01       Impact factor: 25.606

10.  NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells.

Authors:  Blandine C Mercier; Erwan Ventre; Marie-Laure Fogeron; Anne-Laure Debaud; Martine Tomkowiak; Jacqueline Marvel; Nathalie Bonnefoy
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  17 in total

1.  Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.

Authors:  Deepika Sharma; Ankit Malik; Clifford S Guy; Rajendra Karki; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  Gastroenterology       Date:  2017-12-02       Impact factor: 22.682

Review 2.  Context-dependent functions of pattern recognition receptors in cancer.

Authors:  Si Ming Man; Brendan J Jenkins
Journal:  Nat Rev Cancer       Date:  2022-03-30       Impact factor: 69.800

3.  MicroRNA-146a controls functional plasticity in γδ T cells by targeting NOD1.

Authors:  Nina Schmolka; Pedro H Papotto; Paula Vargas Romero; Tiago Amado; Francisco J Enguita; Ana Amorim; Ana F Rodrigues; Katrina E Gordon; Ana S Coroadinha; Mark Boldin; Karine Serre; Amy H Buck; Anita Q Gomes; Bruno Silva-Santos
Journal:  Sci Immunol       Date:  2018-05-04

Review 4.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

Review 5.  NOD1-Targeted Immunonutrition Approaches: On the Way from Disease to Health.

Authors:  Victoria Fernández-García; Silvia González-Ramos; Paloma Martín-Sanz; José M Laparra; Lisardo Boscá
Journal:  Biomedicines       Date:  2021-05-06

Review 6.  Microbiota, Inflammation and Colorectal Cancer.

Authors:  Cécily Lucas; Nicolas Barnich; Hang Thi Thu Nguyen
Journal:  Int J Mol Sci       Date:  2017-06-20       Impact factor: 5.923

7.  NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet.

Authors:  Silvia González-Ramos; Marta Paz-García; Victoria Fernández-García; Kevin J Portune; Emilio F Acosta-Medina; Yolanda Sanz; Antonio Castrillo; Paloma Martín-Sanz; Maria Jesus Obregon; Lisardo Boscá
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

8.  Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis.

Authors:  Amy I Yu; Lili Zhao; Kathryn A Eaton; Sharon Ho; Jiachen Chen; Sara Poe; James Becker; Allison Gonzalez; Delaney McKinstry; Muneer Hasso; Jonny Mendoza-Castrejon; Joel Whitfield; Charles Koumpouras; Patrick D Schloss; Eric C Martens; Grace Y Chen
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

9.  Analysis of lncRNA, miRNA, and mRNA Expression Profiling in Type I IFN and Type II IFN Overexpressed in Porcine Alveolar Macrophages.

Authors:  Congcong Li; Haoyuan Han; Xiuling Li; Jiao Wu; Xinfeng Li; Hui Niu; Wantao Li
Journal:  Int J Genomics       Date:  2021-06-16       Impact factor: 2.326

10.  NOD1 modulates IL-10 signalling in human dendritic cells.

Authors:  Theresa Neuper; Kornelia Ellwanger; Harald Schwarz; Thomas A Kufer; Albert Duschl; Jutta Horejs-Hoeck
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.